Search
HCV-086
go.drugbank.com/drugs/DB05884ExperimentalHCV-086 is a small molecule antiviral designed to block an enzyme required for the replication of the hepatitis C virus.
BL-1020
go.drugbank.com/drugs/DB05687InvestigationalBL-1020 is a first in class novel compound for the treatment of schizophrenia. It is being developed by BioLineRx (BioLine).
Toloxatone
go.drugbank.com/drugs/DB09245ExperimentalToloxatone is an antidepressant agent, the first ever use of which was in France, 1984. It acts as a selective and reversible inhibitor of monoamine oxidase-A (MOA) .
Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesNavarixin
go.drugbank.com/drugs/DB11711InvestigationalNavarixin has been investigated for the treatment of Asthma.
Sarcosine
go.drugbank.com/drugs/DB12519InvestigationalSarcosine has been investigated for the treatment of Schizophrenia.
Pyronaridine
go.drugbank.com/drugs/DB12975InvestigationalPyronaridine has been investigated for the treatment of Malaria.
Abivertinib
go.drugbank.com/drugs/DB15327Investigational[L17383] It has been investigated for use in the treatment of non-small cell lung cancer (NSCLC) and B-cell malignancies.
Categories: Experimental Unapproved Treatments for COVID-19Alferminogene tadenovec
go.drugbank.com/drugs/DB05306InvestigationalAlferminogene tadenovec, Cardium’s lead product candidate, is being developed for the potential treatment of myocardial ischemia that gives rise to angina symptoms associated with coronary heart disease
Milveterol
go.drugbank.com/drugs/DB05043InvestigationalGSK159797 ('797) is an inhaled, longer-acting Beta2 agonist developed for the treatment of respiratory disease such as asthma and COPD.
Gluconolactone
go.drugbank.com/drugs/DB04564ApprovedGluconolactone is a naturally-occurring food additive used as a sequestrant, an acidifier, or a curing, pickling, or leavening agent. It is a cyclic ester of D-gluconic acid.